APA (7th ed.) Citation

Hiestand, B., Levy, P., Peacock, W. F., Baumann, B. M., Nowak, R. M., Hsu, A., . . . Schrock, J. W. Intravenous nicardipine and labetalol use in hypertensive patients with signs or symptoms suggestive of end-organ damage in the emergency department: A subgroup analysis of the CLUE trial. BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Hiestand, Brian, et al. Intravenous Nicardipine and Labetalol Use in Hypertensive Patients with Signs or Symptoms Suggestive of End-organ Damage in the Emergency Department: A Subgroup Analysis of the CLUE Trial. BMJ Publishing Group.

MLA (9th ed.) Citation

Hiestand, Brian, et al. Intravenous Nicardipine and Labetalol Use in Hypertensive Patients with Signs or Symptoms Suggestive of End-organ Damage in the Emergency Department: A Subgroup Analysis of the CLUE Trial. BMJ Publishing Group.

Warning: These citations may not always be 100% accurate.